GHK-Cu for Skin and Hair: What the Research Actually Shows
GHK-Cu has drawn interest for its role in collagen production, skin repair and hair growth. Human studies have reported improvements in wrinkles and, more recently, eyebrow growth. The most useful findings come from looking closely at what changed in each study.
For skin, the research spans cosmetic serums and wound care. For hair, a small eyebrow trial offers an early look at GHK-Cu in people, alongside laboratory work on related copper peptides. Here is what those studies found.
What GHK-Cu is
GHK is a short chain of three amino acids: glycine, histidine and lysine. Amino acids are the building blocks of peptides and proteins. The “Cu” identifies copper bound to that chain.
Researchers became interested in GHK-Cu partly because of its effect on fibroblasts, cells that help build and maintain connective tissue. In a 1988 experiment, it increased collagen production in fibroblast cultures. Collagen gives tissue structural support, making this a useful starting point for skin-repair research. Maquart and colleagues.
The evidence at a glance
| Area of research | Study | Main finding |
|---|---|---|
| Facial wrinkles | GHK-Cu serum, eight weeks | Improved wrinkle measurements. Study |
| Recovery after laser resurfacing | Skin-care regimens, 13 participants | Higher patient ratings; no clear difference in measured skin outcomes. Study |
| Sparse eyebrows | GHK-Cu serum, 18 adults, 12 weeks | Modest gains in hair count and diameter. Study |
| Hair-follicle biology | Related peptide AHK-Cu, laboratory study | Longer isolated follicles and increased growth of cultured cells. Study |
What the human skin studies found
Wrinkle changes after eight weeks
A 2016 study enrolled 40 women aged 40–65; 39 completed it. The GHK-Cu serum used a fat-based carrier to help deliver the peptide into skin. In the 20-woman comparison with a control serum, average wrinkle volume fell by 24.1% versus 15.0% over eight weeks, measured with a skin-imaging instrument.
The finding concerns the complete formula: the control lacked both peptide and carrier. The test serum was always applied on the right, leaving possible side differences. Snowberry co-funded the research. Badenhorst and colleagues.
Skin quality after laser treatment
In a 2006 study after carbon dioxide laser resurfacing, participants using a GHK-Cu regimen rated their skin's improvement more highly. Evaluators found no statistically significant difference between regimens for redness, wrinkles and overall skin quality. Thirteen people completed the trial. Miller and colleagues.
Wound repair
A 1994 trial found better closure of diabetic foot ulcers when a topical GHK-Cu gel was added to standardized wound care. An earlier trial in venous leg ulcers found no significant healing advantage for a copper-tripeptide cream over its base. These are two distinct wound conditions, treated with different products. Diabetic-ulcer trial, venous-ulcer trial.
What the hair research found
A small trial in sparse eyebrows
A 2026 conference paper studied 18 adults with sparse eyebrows. Each person received GHK-Cu serum on one eyebrow and the matching serum base on the other.
At 12 weeks, the treated side had about 1.8 more counted hairs in a 1 cm² area than the comparison side, on average. The authors also reported greater hair diameter and better appearance ratings. This was a modest result from a small, short trial, with longer-term results still an open question. Bo and colleagues.
Why AHK-Cu appears in the hair research
A frequently cited 2007 paper tested AHK-Cu, a related copper peptide whose first amino acid is alanine. GHK-Cu starts with glycine.
In that laboratory study, isolated human hair follicles grew longer, and cultured dermal papilla cells increased in number. These cells help regulate hair-follicle growth. The findings help explain scientific interest in copper peptides and hair biology. Pyo and colleagues.
The scalp trial involving ALAVAX
A 2016 trial followed 45 men with pattern hair loss for six months. It tested ALAVAX, which links GHK to 5-aminolevulinic acid instead of copper. One treatment group had a favorable hair-count comparison; differences in hair length and thickness between groups were not statistically significant. Lee and colleagues.
For GHK-Cu itself, dependable evidence of scalp regrowth remains a gap. Keeping the compounds' names clear makes these studies much easier to follow: GHK-Cu for the eyebrow trial, AHK-Cu for the laboratory work, and ALAVAX for the scalp trial.
Understanding the product behind a study
A serum's concentration, other ingredients and carrier are part of the product being tested. Those details help you compare a study with a product listing.
For example, WPA's GHK-Cu comparison page lists research vials by milligrams. That number tells you the amount of material in the vial. A serum's concentration tells you how much ingredient is present relative to the finished mixture.
A certificate of analysis, or COA, adds information about a tested sample's identity, purity and amount. Look for the matching batch, the test method and the reported result. WPA's guide to reading a peptide COA explains each part. These records help assess the material; human studies answer questions about skin and hair benefits.
Safety findings
The eyebrow study reported no adverse reactions among its 18 participants over 12 weeks. In the wrinkle trial, one woman stopped after minor skin reactions on both sides of her face, where she used the GHK-Cu serum and a separate comparison product. Her symptoms resolved without treatment. Larger studies with longer follow-up would give a fuller safety picture. Wrinkle study.
Injectable GHK-Cu has a separate safety concern. The FDA identifies limited human safety data and potential immune-response risks linked to impurities or peptide aggregation, meaning molecules collecting into clusters. FDA safety assessment.
GHK-Cu skin and hair FAQs
What benefits have human studies reported?
The studies covered here report improved wrinkle measurements with a topical serum, modest eyebrow gains and better healing in a diabetic-foot-ulcer trial. Other trials found no significant advantage in measured outcomes after laser treatment or in venous-ulcer healing.
How does GHK-Cu relate to collagen?
GHK-Cu increased collagen production in cultured fibroblasts. These cells help make the tissue's supporting structure. That response is one reason researchers have studied the peptide for skin repair. Collagen experiment.
Can GHK-Cu regrow thinning scalp hair?
Its effectiveness for scalp pattern hair loss is still uncertain. The direct human GHK-Cu hair study discussed here concerns eyebrows; the scalp trial tested ALAVAX. For a scalp claim, look for a human study testing GHK-Cu and measuring scalp hair growth.
How are GHK-Cu and AHK-Cu different?
Their first amino acid differs: glycine in GHK-Cu, alanine in AHK-Cu. Both are copper-peptide complexes. The 2007 laboratory hair paper tested AHK-Cu, so that is the name to look for in its methods. AHK-Cu study.
How long did the studies take?
The wrinkle trial lasted eight weeks, and the eyebrow trial lasted 12. These give the time frames in which researchers measured changes with those specific serums.
Are injections more effective than topical GHK-Cu?
That comparison remains unanswered by the studies covered here. The human wrinkle and eyebrow findings came from topical serums. Injectable preparations also have the separate safety concerns described above.
What should I look for in safety research?
Look for the exact product and route, the number of participants, follow-up length and reported side effects. These details are more useful than a product's “natural” label when judging how well its safety has been studied.
What does a high-purity COA tell me?
It reports the result of a purity test on a sample. Check how the test was performed and whether the sample's batch matches the listing. The WPA COA guide explains how to read that result alongside identity and amount testing.
Compare the material behind the claim
The skin studies give GHK-Cu a concrete research history, and the eyebrow findings add a small human hair study worth following. A useful comparison starts with the compound's identity, the finished formulation and the outcome that interests you.
For research-product details, explore WPA's GHK-Cu listings. Compare vial amounts and available testing records, using the COA guide to understand the documentation.
Some links on WPA's comparison pages are affiliate links. WPA may earn a commission at no additional cost to you.
Sources and scope
This educational article draws on primary study reports and abstracts, including the full wrinkle and eyebrow papers. The main source review was completed October 15, 2026; the wrinkle figures and FDA safety statement were rechecked October 26. Prepared with AI assistance.